Brief: Lineage Cell Therapeutics Conducts Sale Of Shares In Oncocyte Corporation
April 24 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS CONDUCTS SALE OF SHARES IN
ONCOCYTE
CORPORATION
* LINEAGE CELL THERAPEUTICS INC - PRICING OF SALE OF 1.7
MILLION
ONCOCYTE SHARES AT A PRICE TO BUYERS OF $2.27 PER SHARE
* LINEAGE CELL THERAPEUTICS INC - NET PROCEEDS FROM SALE OF
ONCOCYTE SHARES WERE ABOUT $3.7 MILLION
Source text for Eikon: ID:nBw5M4f2la
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million